Ophthalmology · page 3

SGLT2 inhibitors are associated with slower diabetic retinopathy progression

A meta-analysis of 1.8 million patients links SGLT2 inhibitors to less retinopathy and macular oedema progression than other glucose-lowering drugs, adding a dexamethasone implant to aflibercept clears oedema faster without improving vision, and a glaucoma drop is recalled for a container that will not deliver a drop.